Literature DB >> 28209711

Serotype 3 pneumococci sequester platelet-derived human thrombospondin-1 via the adhesin and immune evasion protein Hic.

Ulrike Binsker1, Thomas P Kohler2, Krystin Krauel3, Sylvia Kohler1, Johanna Habermeyer1, Hansjörg Schwertz3, Sven Hammerschmidt1.   

Abstract

Streptococcus pneumoniae serotype 3 strains emerge frequently within clinical isolates of invasive diseases. Bacterial invasion into deeper tissues is associated with colonization and immune evasion mechanisms. Thus, pneumococci express a versatile repertoire of surface proteins sequestering and interacting specifically with components of the human extracellular matrix and serum. Hic, a PspC-like pneumococcal surface protein, possesses vitronectin and factor H binding activity. Here, we show that heterologously expressed Hic domains interact, similar to the classical PspC molecule, with human matricellular thrombospondin-1 (hTSP-1). Binding studies with isolated human thrombospondin-1 and various Hic domains suggest that the interaction between hTSP-1 and Hic differs from binding to vitronectin and factor H. Binding of Hic to hTSP-1 is inhibited by heparin and chondroitin sulfate A, indicating binding to the N-terminal globular domain or type I repeats of hTSP-1. Competitive inhibition experiments with other pneumococcal hTSP-1 adhesins demonstrated that PspC and PspC-like Hic recognize similar domains, whereas PavB and Hic can bind simultaneously to hTSP-1. In conclusion, Hic binds specifically hTSP-1; however, truncation in the N-terminal part of Hic decreases the binding activity, suggesting that the full length of the α-helical regions of Hic is required for an optimal interaction.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Hic; Streptococcus pneumoniae; adhesion; bacterial pathogenesis; extracellular matrix protein; human serum; pneumococcal surface protein C; surface plasmon resonance (SPR); thrombospondin

Mesh:

Substances:

Year:  2017        PMID: 28209711      PMCID: PMC5392572          DOI: 10.1074/jbc.M116.760504

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  49 in total

Review 1.  Structures of thrombospondins.

Authors:  C B Carlson; J Lawler; D F Mosher
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

2.  Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae.

Authors:  J O Kim; J N Weiser
Journal:  J Infect Dis       Date:  1998-02       Impact factor: 5.226

3.  Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells.

Authors:  Sven Hammerschmidt; Sonja Wolff; Andreas Hocke; Simone Rosseau; Ellruth Müller; Manfred Rohde
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

4.  Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix.

Authors:  E A Jaffe; J T Ruggiero; L K Leung; M J Doyle; P J McKeown-Longo; D F Mosher
Journal:  Proc Natl Acad Sci U S A       Date:  1983-02       Impact factor: 11.205

5.  Factor H co-purifies with thrombospondin isolated from platelet secretate.

Authors:  J A Carron; R C Bates; A I Smith; T Tetoz; A Arellano; D L Gordon; G F Burns
Journal:  Biochim Biophys Acta       Date:  1996-04-17

6.  Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif.

Authors:  S Hammerschmidt; M P Tillig; S Wolff; J P Vaerman; G S Chhatwal
Journal:  Mol Microbiol       Date:  2000-05       Impact factor: 3.501

7.  SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component.

Authors:  S Hammerschmidt; S R Talay; P Brandtzaeg; G S Chhatwal
Journal:  Mol Microbiol       Date:  1997-09       Impact factor: 3.501

8.  Expression of thrombospondins by endothelial cells. Injury is correlated with TSP-1.

Authors:  M J Reed; L Iruela-Arispe; E R O'Brien; T Truong; T LaBell; P Bornstein; E H Sage
Journal:  Am J Pathol       Date:  1995-10       Impact factor: 4.307

Review 9.  Current understanding of the thrombospondin-1 interactome.

Authors:  Andrea Resovi; Denise Pinessi; Giovanna Chiorino; Giulia Taraboletti
Journal:  Matrix Biol       Date:  2014-01-27       Impact factor: 11.583

10.  Changes in capsular serotype alter the surface exposure of pneumococcal adhesins and impact virulence.

Authors:  Carlos J Sanchez; Cecilia A Hinojosa; Pooja Shivshankar; Catherine Hyams; Emilie Camberlein; Jeremy S Brown; Carlos J Orihuela
Journal:  PLoS One       Date:  2011-10-19       Impact factor: 3.240

View more
  5 in total

Review 1.  Contribution of Human Thrombospondin-1 to the Pathogenesis of Gram-Positive Bacteria.

Authors:  Ulrike Binsker; Thomas P Kohler; Sven Hammerschmidt
Journal:  J Innate Immun       Date:  2019-02-27       Impact factor: 7.349

Review 2.  The matricellular protein thrombospondin-1 in lung inflammation and injury.

Authors:  Mohammadreza Tabary; Atish Gheware; Hernán F Peñaloza; Janet S Lee
Journal:  Am J Physiol Cell Physiol       Date:  2022-08-01       Impact factor: 5.282

3.  Molecular analyses identifies new domains and structural differences among Streptococcus pneumoniae immune evasion proteins PspC and Hic.

Authors:  Shanshan Du; Cláudia Vilhena; Samantha King; Alfredo Sahagún-Ruiz; Sven Hammerschmidt; Christine Skerka; Peter F Zipfel
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

Review 4.  Platelets, Bacterial Adhesins and the Pneumococcus.

Authors:  Kristin Jahn; Thomas P Kohler; Lena-Sophie Swiatek; Sergej Wiebe; Sven Hammerschmidt
Journal:  Cells       Date:  2022-03-25       Impact factor: 6.600

5.  Streptococcus pneumoniae binds collagens and C1q via the SSURE repeats of the PfbB adhesin.

Authors:  Giuseppe Valerio De Gaetano; Francesco Coppolino; Germana Lentini; Agata Famà; Chiara Cullotta; Ivana Raffaele; Chiara Motta; Giuseppe Teti; Pietro Speziale; Giampiero Pietrocola; Concetta Beninati
Journal:  Mol Microbiol       Date:  2022-05-30       Impact factor: 3.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.